Showing results (1121-1130 of 2,811) with videos related to
Sort By:
Pageof 282
Expert Opinion on Drug Safety|August 23, 2023
Ocular adverse events of cenegermin used in neurotrophic keratopathy: an analysis of the FDA adverse event reporting system databaseYunfei Li, Haiyun Yang, Yuan Gao, et al.Expert Opinion on Drug Safety|August 18, 2023
United States' regulatory approved pharmacotherapies for nuclear reactor explosions and anthrax-associated bioterrorismCharles L Bennett, Peter Georgantopoulos, Robert Peter Gale, et al.Expert Opinion on Drug Safety|August 14, 2023
A systematic review and meta-analysis of the prevalence and association between levonorgestrel and ectopic pregnancyBannawich Sapapsap, Nattawut Leelakanok, Kansak Boonpattharatthiti, et al.Expert Opinion on Drug Safety|October 20, 2023
Balancing the risk of stroke and bleeding in atrial fibrillation patients with a history of fallsNang Khaing Zar Latt, Peter Calvert, Gregory Y H LipExpert Opinion on Drug Safety|October 5, 2023
The role of co-morbidities in the development of an AEFI after COVID-19 vaccination in a large prospective cohort with patient-reported outcomes in the NetherlandsC Ouaddouh, J W Duijster, T Lieber, et al.Expert Opinion on Drug Safety|July 10, 2023
Cardiac arrhythmias associated with anaplastic lymphoma kinase (ALK) inhibitors: an analysis of the FDA Adverse Event Reporting System (FAERS)Feifei Wang, Guishui Xu, Xinan WuExpert Opinion on Drug Safety|July 12, 2023
Will the future of pharmacovigilance be more automated?Francesco Salvo, Joelle Micallef, Amir Lahouegue, et al.Expert Opinion on Drug Safety|July 3, 2023
The safety of ceftolozane/tazobactam for the treatment of complicated urinary tract infectionsMatteo Bassetti, Antonio Vena, Daniele Roberto GiacobbeExpert Opinion on Drug Safety|June 26, 2023
A drug safety evaluation of pemigatinib for advanced cholangiocarcinomaPedro Luiz Serrano Uson, Jeremiah Bearss, Hani M Babiker, et al.Expert Opinion on Drug Safety|September 29, 2020
Frequency of real-world reported adverse drug reactions in rheumatoid arthritis patientsEline L Giraud, Naomi T Jessurun, Florence P A M van Hunsel, et al.Pageof 282